Hughes & Company

Private Equity Fort Lauderdale, United States

Overview

Hughes & Company is a private equity firm based in Chicago, Illinois, focusing exclusively on lower middle market healthcare software and technology-enabled service companies. The firm seeks to create substantial value through revenue and EBITDA growth by partnering with companies that have demonstrated business models and sustainable margin structures. Hughes & Company typically invests between $5 million and $50 million per company, engaging in both minority and majority control transactions, including growth equity, leveraged buyouts, spin-outs, and strategic combinations. The firm's investment strategy emphasizes active involvement with portfolio companies, aiming to accelerate growth, expand margins, enhance customer value propositions, and increase long-term retention. This approach is supported by an extensive network of longstanding relationships with senior executives, advisors, and partners across the healthcare software and technology-enabled service market. Hughes & Company does not invest in clinical service, pre-revenue, pharmaceutical, biotechnology, or highly capital-intensive businesses. Since its inception in 2011, Hughes & Company has built a successful track record, closing its first private equity fund, Hughes Growth Equity Fund I, L.P., at $116 million in July 2021, exceeding its original target of $100 million. The firm made its first investment from this fund in December 2020 in Azara Healthcare, a population health management software provider. In September 2025, Hughes & Company closed its second private equity fund, Hughes Growth Equity Fund II, L.P., at its hard cap of $260 million, exceeding its original target of $200 million. The firm continues to focus on investments that improve patient outcomes and operational efficiency within the healthcare sector. Hughes & Company's portfolio includes investments in companies such as Health Data Innovations, a healthcare data integration platform serving value-based care providers and payers, and Voluware, a provider of solutions to speed and simplify prior authorizations. These investments reflect the firm's commitment to supporting innovative companies that enhance healthcare delivery through technology and data integration.

Get the full list of 54,000+ investors

Hughes & Company and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Hughes & Company

What sectors does Hughes & Company invest in?

Hughes & Company invests in Healthcare, Software and Technology-Enabled Services, and is based in Fort Lauderdale, United States. Hughes & Company is listed as a private equity in the ConnectSafely investor database.

What stage does Hughes & Company invest at?

Hughes & Company backs companies at Growth and Late Stage, writing cheques of 5M - 50M.

Which regions does Hughes & Company invest in?

Hughes & Company invests across United States.

Who are the partners at Hughes & Company?

Team members listed for Hughes & Company include Dan Hughes (Managing Director) and William Jeska (Director Of Operations).

How do I contact Hughes & Company?

Hughes & Company's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database